Agilent Technologies, Inc. (LON:0HAV)

London flag London · Delayed Price · Currency is GBP · Price in USD
118.94
-1.02 (-0.85%)
At close: Jul 30, 2025

Revenue by Product

Fiscal year is November - October.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2012 - 2019
Life Sciences & Applied Markets
3.22B
Log In
Log In
Log In
Log In
Upgrade
Life Sciences & Applied Markets Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics
1.65B
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Revenue (Pre-FY2025 Reporting)
1.64B
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Revenue (Pre-FY2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is November - October.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2012 - 2019
Other
-177.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Life Sciences & Applied Markets Income from Operations
877.00M
Log In
Log In
Log In
Log In
Upgrade
Life Sciences & Applied Markets Income from Operations Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-177.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics Income from Operations
320.00M
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics Income from Operations Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Income from Operations (Pre-FY2025 Reporting)
524.00M
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Income from Operations (Pre-FY2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade